ArticleDiscover nano2026
Eco-friendly optimization and green biosynthesis of Cu(II) nanocomposites from Stereum ostrea biomass extract: enhanced antibiofilm efficacy against pathogenic bacteria.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application and Potential of Local Drug Delivery Systems for Antibacterial Treatment of Periodontitis.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents an eco-friendly approach to optimizing the extraction of bioactive compounds from false turkey-tail (Stereum ostrea) mushroom biomass and their application in green synthesis of Cu(II) nanocomposites for antibiofilm applications. Key extraction parameter biomass concentration (0.15%), solvent (distilled water), time (60 min), and temperature (20 °C) were systematically varied and evaluated using UV-Vis spectroscopy to maximize yield and bioactive quality, aligning with sustainable green chemistry principles. Morphological analysis via metallurgical microscopy at 10 × and 20 × magnifications revealed structural changes in treated versus untreated biomass, while Fourier-transform infrared spectroscopy (FTIR) identified functional groups (e.g., hydroxyl and carbonyl) serving as reducing and stabilizing agents. The optimized aqueous extract facilitated room-temperature biosynthesis of Cu(II) nanoparticles, confirmed by scanning electron microscopy (SEM) for uniform morphology. Antibiofilm activity was assessed in vitro using crystal violet broth assays against Staphylococcus aureus and Escherichia coli. The extract exhibited potent inhibition (71% for S. aureus and 37% for E. coli), with nanocomposites enhancing efficacy through synergistic effects. This integrated methodology demonstrates the potential of mushroom-derived nanomaterials as biodegradable, non-toxic antimicrobial agents, promoting sustainable alternatives to conventional chemical syntheses in biomedical and environmental sectors. By minimizing energy use and hazardous solvents, this work advances green nanotechnology for biofilm-related challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.